Grantham Mayo Van Otterloo & Co. LLC Sells 2,200 Shares of Pediatrix Medical Group, Inc. (NYSE:MD)

Grantham Mayo Van Otterloo & Co. LLC lessened its position in shares of Pediatrix Medical Group, Inc. (NYSE:MD) by 9.2% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 21,700 shares of the company’s stock after selling 2,200 shares during the period. Grantham Mayo Van Otterloo & Co. LLC’s holdings in Pediatrix Medical Group were worth $324,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of MD. Eagle Bay Advisors LLC increased its stake in Pediatrix Medical Group by 149.7% in the first quarter. Eagle Bay Advisors LLC now owns 1,823 shares of the company’s stock valued at $27,000 after purchasing an additional 1,093 shares in the last quarter. Ronald Blue Trust Inc. increased its stake in Pediatrix Medical Group by 94.6% in the first quarter. Ronald Blue Trust Inc. now owns 1,938 shares of the company’s stock valued at $29,000 after purchasing an additional 942 shares in the last quarter. Tower Research Capital LLC TRC increased its stake in Pediatrix Medical Group by 90.6% in the first quarter. Tower Research Capital LLC TRC now owns 2,262 shares of the company’s stock valued at $34,000 after purchasing an additional 1,075 shares in the last quarter. Royal Bank of Canada increased its position in shares of Pediatrix Medical Group by 97.3% during the third quarter. Royal Bank of Canada now owns 2,166 shares of the company’s stock worth $35,000 after acquiring an additional 1,068 shares in the last quarter. Finally, Quadrant Capital Group LLC increased its position in shares of Pediatrix Medical Group by 149.7% during the fourth quarter. Quadrant Capital Group LLC now owns 2,927 shares of the company’s stock worth $43,000 after acquiring an additional 1,755 shares in the last quarter. Institutional investors own 96.89% of the company’s stock.

Pediatrix Medical Group Trading Up 3.2 %

NYSE:MD opened at $13.04 on Thursday. The company has a debt-to-equity ratio of 0.71, a current ratio of 1.24 and a quick ratio of 1.24. The firm has a 50-day moving average of $14.14 and a 200-day moving average of $14.26. The company has a market cap of $1.09 billion, a PE ratio of 10.52, a PEG ratio of 1.94 and a beta of 1.72. Pediatrix Medical Group, Inc. has a one year low of $12.59 and a one year high of $19.63.

Pediatrix Medical Group (NYSE:MD) last released its quarterly earnings results on Thursday, August 3rd. The company reported $0.39 earnings per share for the quarter, missing the consensus estimate of $0.40 by ($0.01). Pediatrix Medical Group had a return on equity of 12.81% and a net margin of 5.16%. The firm had revenue of $500.60 million for the quarter, compared to analysts’ expectations of $495.88 million. During the same quarter last year, the firm posted $0.43 earnings per share. The firm’s revenue for the quarter was up 3.0% compared to the same quarter last year. As a group, equities research analysts expect that Pediatrix Medical Group, Inc. will post 1.43 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Separately, StockNews.com assumed coverage on shares of Pediatrix Medical Group in a research report on Thursday, August 17th. They set a “hold” rating for the company. Three investment analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $16.60.

Insider Buying and Selling at Pediatrix Medical Group

In other Pediatrix Medical Group news, CEO James D. Swift sold 13,193 shares of the business’s stock in a transaction dated Wednesday, June 14th. The shares were sold at an average price of $14.14, for a total value of $186,549.02. Following the transaction, the chief executive officer now directly owns 96,638 shares in the company, valued at $1,366,461.32. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Corporate insiders own 2.00% of the company’s stock.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.